April 7, 2021 Development of a regulatory-ready clinical trial simulation tool for Duchenne muscular dystrophy poster WMS 2020
April 7, 2021 Development of Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Abstract WMS 2019
April 7, 2021 Development of Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Poster WMS 2019
April 6, 2021 C-Path Welcomes Dr. Ramona Belfiore Oshan as D-RSC Associate Director C-Path is pleased to welcome Ramona Belfiore Oshan, Ph.D., as the new Associate Director for its Duchenne Regulatory Science
March 31, 2021 View Now: 2021 PSTC Virtual Workshop—March 31, 2021 The Predictive Safety Testing Consortium (PSTC) launched its 15th anniversary celebration with a virtual public workshop. Scientis
March 31, 2021 Cures Within Reach Names CURE ID as 2021 Patient Impact Awardee Cures Within Reach, a global nonprofit leading the use of repurposing research to help improve patients’ lives, has a
March 31, 2021 Introducing Dr. Alexandre Bétourné, RDCA-DAP Scientific Director C-Path is pleased to welcome Alexandre Bétourné, PhD, PharmD, as its new Scientific Director for the Rare Disease Cures Accelera
March 25, 2021 C-Path Launches Acute Kidney Injury Project with Support from FDA Project aims to develop improved predictive and detection tools for kidney injury TUCSON, March 25, 2021 — Acute kidney injury (
March 20, 2021 Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel